- Home
- MIST vs DAKT Comparison
MIST vs DAKT Comparison
Compare MIST & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | DAKT |
|---|---|---|
| Founded | 2003 | 1968 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 944.7M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MIST | DAKT |
|---|---|---|
| Price | $1.32 | $20.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 235.4K |
| Earning Date | 05-13-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.75 |
| Revenue | N/A | ★ $608,932,000.00 |
| Revenue This Year | $2,915.14 | $12.06 |
| Revenue Next Year | N/A | $9.16 |
| P/E Ratio | ★ N/A | $27.11 |
| Revenue Growth | N/A | ★ 6.89 |
| 52 Week Low | $1.00 | $13.30 |
| 52 Week High | $3.06 | $28.27 |
Technical Indicators
Market Signals| Indicator | MIST | DAKT |
|---|---|---|
| Relative Strength Index (RSI) | 30.80 | 55.51 |
| Support Level | $1.00 | $18.76 |
| Resistance Level | $2.30 | $21.14 |
| Average True Range (ATR) | 0.11 | 0.55 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 3.48 | 78.97 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About DAKT Daktronics Inc.
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.